|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Veracyte, Inc.
| Veracyte, Inc. 12357-A Riata Trace Pky, Bldg 5, Suite 100 Austin, TX 78727 | |
| | Phone: | (650) 243-6300 | Fax: | (650) 243-6301 | Year Established: | 2008 | Ticker: | VCYT | Exchange: | NASDAQ | Main Contact: | Christopher M. Hall, President & COO | | Other Contacts: | John W. Hanna, CCO Julie A. Brooks, Executive VP & General Counsel Keith Kennedy, CFO Ashish Kheterpal, CIO Bonnie Anderson, Co-Founder, Chairman & CEO Giulia C. Kennedy, Ph.D., CSO & Medical Affairs Officer
| | Company Description | Veracyte is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company's products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary. Since its founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in South San Francisco, California. | |
|
|
|
|
|